Olli-Pekka Pulkka

Title: Olli-Pekka Pulkka: Innovator in Cancer Treatment

Introduction

Olli-Pekka Pulkka is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medical research, particularly in the treatment of solid tumors. His innovative work focuses on the development of compositions that utilize phosphodiesterase inhibitors.

Latest Patents

Olli-Pekka Pulkka holds a patent for "Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient." This invention relates to a composition that includes a phosphodiesterase inhibitor, such as anagrelide or a salt thereof. The patent specifically addresses the treatment of solid tumors, including gastrointestinal stromal tumors (GIST) and liposarcomas, which express phosphodiesterase 3 enzymes in human patients. He has 1 patent to his name.

Career Highlights

Olli-Pekka Pulkka is associated with Sartar Therapeutics Ltd., where he continues to advance his research and innovations. His work is pivotal in the ongoing efforts to improve cancer treatment options.

Collaborations

Olli-Pekka collaborates with esteemed colleagues, including Harri Sihto and Olli Kallioniemi. Their combined expertise contributes to the development of effective therapeutic solutions.

Conclusion

Olli-Pekka Pulkka is a dedicated inventor whose work in cancer treatment through phosphodiesterase inhibitors showcases his commitment to advancing medical science. His contributions are vital in the fight against solid tumors, and his ongoing research promises to impact patient care positively.